{"id":557001,"date":"2026-05-11T03:00:00","date_gmt":"2026-05-11T01:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/tendencia-a-la-terapia-combinada-precoz-y-nuevas-estrategias-para-reducir-la-lpa\/"},"modified":"2026-05-18T13:20:37","modified_gmt":"2026-05-18T11:20:37","slug":"tendencia-a-la-terapia-combinada-precoz-y-nuevas-estrategias-para-reducir-la-lpa","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/tendencia-a-la-terapia-combinada-precoz-y-nuevas-estrategias-para-reducir-la-lpa\/","title":{"rendered":"Tendencia a la terapia combinada precoz y nuevas estrategias para reducir la Lp(a)"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>La prevenci\u00f3n secundaria tras un s\u00edndrome coronario agudo (SCA) es crucial para mejorar la calidad de vida y reducir las tasas de morbilidad y mortalidad. Los niveles elevados de l\u00edpidos en sangre, como el colesterol LDL y la lipoprote\u00edna(a), son factores de riesgo importantes. Adem\u00e1s de la estrategia cl\u00e1sica de reducir el colesterol LDL con estatinas, ezetimiba, \u00e1cido bempedoico, PCSK-9-Ak y si-ARN, ahora se presta m\u00e1s atenci\u00f3n a las estrategias innovadoras para reducir espec\u00edficamente la lipoprote\u00edna(a). Aunque las sustancias activas en este \u00e1mbito a\u00fan est\u00e1n en fase de desarrollo, los resultados obtenidos hasta ahora son alentadores.     <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Ftendencia-a-la-terapia-combinada-precoz-y-nuevas-estrategias-para-reducir-la-lpa%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>La prevenci\u00f3n secundaria tras un s\u00edndrome coronario agudo (SCA) es crucial para mejorar la calidad de vida y reducir las tasas de morbilidad y mortalidad. Los niveles elevados de l\u00edpidos&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Ftendencia-a-la-terapia-combinada-precoz-y-nuevas-estrategias-para-reducir-la-lpa%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":557002,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Prevenci\u00f3n secundaria tras un SCA: tratamiento optimizado individualmente de los l\u00edpidos","footnotes":""},"category":[11324,11483,11475,11288,11552],"tags":[66953,38264,93896,18175,11837,66950,15945,11840,91032,16859,93897,93898,24600,25960,50294],"powerkit_post_featured":[],"class_list":["post-557001","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cardiologia","category-el-congreso-informa","category-estudios","category-medicina-interna-general","category-rx-es","tag-acido-bempedoico-es","tag-acs-es","tag-anticuerpo-pcsk-9","tag-colesterol-es","tag-estatinas","tag-ezetimiba","tag-gestion-de-lipidos","tag-ldl-c-es","tag-lpa","tag-prevencion-secundaria","tag-reduccion-de-lpa","tag-si-arn","tag-sindrome-coronario-agudo","tag-terapia-combinada","tag-terapia-con-estatinas","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-11 08:27:29","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/557001","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=557001"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/557001\/revisions"}],"predecessor-version":[{"id":557003,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/557001\/revisions\/557003"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/557002"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=557001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=557001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=557001"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=557001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}